Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    +1.76 (+2.16%)
     
  • Gold

    2,254.80
    +42.10 (+1.90%)
     
  • Silver

    25.10
    +0.35 (+1.41%)
     
  • EUR/USD

    1.0792
    -0.0037 (-0.35%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2624
    -0.0015 (-0.11%)
     
  • USD/JPY

    151.3600
    +0.1140 (+0.08%)
     
  • Bitcoin USD

    70,915.24
    +1,741.86 (+2.52%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Company News for May 12, 2020

  • Shares of Cellect Biotechnology Ltd. APOP surged 66.7% after the company announced the publication of an article in Bone Marrow Transplantation.

  • Shares of MyoKardia, Inc. MYOK soared 58.6% after the company announced that the primary and secondary endpoints for its Phase 3 EXPLORER clinical trials of Mavacamten were successful.

  • Shares of Amneal Pharmaceuticals, Inc. AMRX rose28.5% after the company’sQ1 earnings of $0.20 per share beat the Zacks Consensus Estimate of $0.08.

  • Shares of Bellerophon Therapeutics, Inc. BLPH gained19.2% after the company disclosed that the FDA has cleared initiation of Phase 3 study for INOpulse inhaled nitric oxide therapy to treat the novel coronavirus.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
MyoKardia Inc (MYOK) : Free Stock Analysis Report
 
Cellect Biotechnology Ltd (APOP) : Free Stock Analysis Report
 
AMNEAL PHARMACEUTICALS INC (AMRX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Advertisement